🇺🇸 FDA
Pipeline program

CAR-CD19 T cell

CGZ001

Unknown gene_therapy active

Quick answer

CAR-CD19 T cell for B Cell Lymphoma is a Unknown program (gene_therapy) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
B Cell Lymphoma
Phase
Unknown
Modality
gene_therapy
Status
active

Clinical trials